These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 15520276
21. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma. Tchougounova E, Kastemar M, Bråsäter D, Holland EC, Westermark B, Uhrbom L. Oncogene; 2007 Sep 20; 26(43):6289-96. PubMed ID: 17438529 [Abstract] [Full Text] [Related]
22. Upregulation of chicken p15INK4b at senescence and in the developing brain. Kim SH, Rowe J, Fujii H, Jones R, Schmierer B, Kong BW, Kuchler K, Foster D, Ish-Horowicz D, Peters G. J Cell Sci; 2006 Jun 15; 119(Pt 12):2435-43. PubMed ID: 16720639 [Abstract] [Full Text] [Related]
23. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. You MJ, Castrillon DH, Bastian BC, O'Hagan RC, Bosenberg MW, Parsons R, Chin L, DePinho RA. Proc Natl Acad Sci U S A; 2002 Feb 05; 99(3):1455-60. PubMed ID: 11818530 [Abstract] [Full Text] [Related]
24. Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures. van Schanke A, van Venrooij GM, Jongsma MJ, Banus HA, Mullenders LH, van Kranen HJ, de Gruijl FR. Cancer Res; 2006 Mar 01; 66(5):2608-15. PubMed ID: 16510579 [Abstract] [Full Text] [Related]
26. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma. Sailasree R, Abhilash A, Sathyan KM, Nalinakumari KR, Thomas S, Kannan S. Cancer Epidemiol Biomarkers Prev; 2008 Feb 15; 17(2):414-20. PubMed ID: 18268126 [Abstract] [Full Text] [Related]
27. Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARF. Bean GR, Bryson AD, Pilie PG, Goldenberg V, Baker JC, Ibarra C, Brander DM, Paisie C, Case NR, Gauthier M, Reynolds PA, Dietze E, Ostrander J, Scott V, Wilke LG, Yee L, Kimler BF, Fabian CJ, Zalles CM, Broadwater G, Tlsty TD, Seewaldt VL. Clin Cancer Res; 2007 Nov 15; 13(22 Pt 1):6834-41. PubMed ID: 18006786 [Abstract] [Full Text] [Related]
28. Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation. Pérez de Castro I, Benet M, Jiménez M, Alzabin S, Malumbres M, Pellicer A. Cancer Res; 2005 Apr 15; 65(8):3249-56. PubMed ID: 15833857 [Abstract] [Full Text] [Related]
29. Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors. Bastide K, Guilly MN, Bernaudin JF, Joubert C, Lectard B, Levalois C, Malfoy B, Chevillard S. Lung Cancer; 2009 Mar 15; 63(3):348-53. PubMed ID: 18656278 [Abstract] [Full Text] [Related]
30. Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency. Menendez S, Camus S, Herreria A, Paramonov I, Morera LB, Collado M, Pekarik V, Maceda I, Edel M, Consiglio A, Sanchez A, Li H, Serrano M, Belmonte JC. Aging Cell; 2012 Feb 15; 11(1):41-50. PubMed ID: 21981310 [Abstract] [Full Text] [Related]
31. The INK4a/ARF locus in murine tumorigenesis. Serrano M. Carcinogenesis; 2000 May 15; 21(5):865-9. PubMed ID: 10783305 [Abstract] [Full Text] [Related]
32. Increased gene dosage of the Ink4/Arf locus does not attenuate atherosclerosis development in hypercholesterolaemic mice. Fuster JJ, Molina-Sánchez P, Jovaní D, Vinué Á, Serrano M, Andrés V. Atherosclerosis; 2012 Mar 15; 221(1):98-105. PubMed ID: 22226369 [Abstract] [Full Text] [Related]
33. Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. Sharp R, Recio JA, Jhappan C, Otsuka T, Liu S, Yu Y, Liu W, Anver M, Navid F, Helman LJ, DePinho RA, Merlino G. Nat Med; 2002 Nov 15; 8(11):1276-80. PubMed ID: 12368906 [Abstract] [Full Text] [Related]
34. The co-transfection of p16(INK4a) and p14(ARF) genes into human lung cancer cell line A549 and the effects on cell growth and chemosensitivity. Xie QC, Hu YD, Wang LL, Chen ZT, Diao XW, Wang ZX, Guan HJ, Zhu B, Sun JG, Duan YZ, Chen FL, Nian WQ. Colloids Surf B Biointerfaces; 2005 Dec 20; 46(3):188-96. PubMed ID: 16337111 [Abstract] [Full Text] [Related]
35. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis. Kanellou P, Zaravinos A, Zioga M, Stratigos A, Baritaki S, Soufla G, Zoras O, Spandidos DA. Cancer Lett; 2008 Jun 08; 264(1):145-61. PubMed ID: 18331779 [Abstract] [Full Text] [Related]
36. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line. Zongaro S, de Stanchina E, Colombo T, D'Incalci M, Giulotto E, Mondello C. Cancer Res; 2005 Dec 15; 65(24):11411-8. PubMed ID: 16357149 [Abstract] [Full Text] [Related]
37. INK4a/Arf is required for suppression of EGFR/DeltaEGFR(2-7)-dependent ERK activation in mouse astrocytes and glioma. Lachat Y, Diserens AC, Nozaki M, Kobayashi H, Hamou MF, Godard S, De Tribolet N, Hegi ME. Oncogene; 2004 Sep 09; 23(41):6854-63. PubMed ID: 15273738 [Abstract] [Full Text] [Related]
38. A conditional mouse model for malignant mesothelioma. Jongsma J, van Montfort E, Vooijs M, Zevenhoven J, Krimpenfort P, van der Valk M, van de Vijver M, Berns A. Cancer Cell; 2008 Mar 09; 13(3):261-71. PubMed ID: 18328429 [Abstract] [Full Text] [Related]
39. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice. Floyd HS, Jennings-Gee JE, Kock ND, Miller MS. Mol Carcinog; 2006 Jul 09; 45(7):506-17. PubMed ID: 16482519 [Abstract] [Full Text] [Related]
40. Hematopoietic malignancies associated with increased Stat5 and Bcl-x(L) expressions in Ink4a/Arf-deficient mice. Sung YH, Park J, Choi B, Kim J, Cheong C, Choi YS, Yang EY, Lee M, Han JS, Park SC, Han TH, Kim TJ, Song J, Rhee K, Lee HW. Mech Ageing Dev; 2005 Jul 09; 126(6-7):732-9. PubMed ID: 15888328 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]